Skip to main content
. 2022 Jan 12;12:803175. doi: 10.3389/fimmu.2021.803175

Figure 4.

Figure 4

Flow diagram. A proposal for personalized rituximab retreatment algorithm based on clinical predictors and early naïve B-cell return in ANCA-associated vasculitis.